SAGARI MURALI: Open Payments
NPI 1053957902 · BEACON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 29 payments from 17 companies in 2025. Trend: 2023 $230 · 2024 $0 · 2025 $700
Food & beverage: $640Education: $60
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $230 |
| Mallinckrodt Hospital Products Inc. | 3 | $65 |
| OPKO Pharmaceuticals, LLC | 3 | $60 |
| Vifor Pharma, Inc. | 2 | $53 |
| Exact Sciences Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Travere Therapeutics, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
Products named: Kerendia, ACTHAR, RAYALDEE, Veltassa, Cologuard Collection Kit, SHINGRIX, PURIFIED CORTROPHIN GEL, KRYSTEXXA.
Industry payments across NY — which companies pay providers there.
